Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay. (2020)

First Author: Houldcroft CJ
Attributed to:  Utilising proteomics to develop anti-HCMV immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fcimb.2020.00275

PubMed Identifier: 32670891

Publication URI: http://europepmc.org/abstract/MED/32670891

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in cellular and infection microbiology

ISSN: 2235-2988